Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Other Operating Expenses: 2009-2024

Historic Other Operating Expenses for Ironwood Pharmaceuticals (IRWD) over the last 13 years, with Dec 2024 value amounting to $2.6 million.

  • Ironwood Pharmaceuticals' Other Operating Expenses rose 13650.00% to $2.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.6 million, marking a year-over-year increase of 152.82%. This contributed to the annual value of $2.6 million for FY2024, which is 99.77% down from last year.
  • Ironwood Pharmaceuticals' Other Operating Expenses amounted to $2.6 million in FY2024, which was down 99.77% from $1.1 billion recorded in FY2023.
  • Over the past 5 years, Ironwood Pharmaceuticals' Other Operating Expenses peaked at $1.1 billion during FY2023, and registered a low of -$44,000 during FY2021.
  • Moreover, its 2-year median value for Other Operating Expenses was $558.2 million (2023), whereas its average is $558.2 million.
  • Data for Ironwood Pharmaceuticals' Other Operating Expenses shows a maximum YoY plummeted of 101.41% (in 2021) over the last 5 years.
  • Yearly analysis of 4 years shows Ironwood Pharmaceuticals' Other Operating Expenses stood at $3.1 million in 2020, then slumped by 101.41% to -$44,000 in 2021, then reached $1.1 billion in 2023, then slumped by 99.77% to $2.6 million in 2024.